Amoxycare, 250 mg, Hard Capsules

Country: Ingilterra

Lingwa: Ingliż

Sors: VMD (Veterinary Medicines Directorate)

Ixtrih issa

Ingredjent attiv:

Amoxicillin

Disponibbli minn:

Cross Vetpharm Group Ltd

Kodiċi ATC:

QJ01CA04

INN (Isem Internazzjonali):

Amoxicillin

Għamla farmaċewtika:

Capsule, hard

Tip ta 'preskrizzjoni:

POM-V - Prescription Only Medicine – Veterinarian

Grupp terapewtiku:

Dogs

Żona terapewtika:

Antimicrobial

L-istatus ta 'awtorizzazzjoni:

Authorized

Data ta 'l-awtorizzazzjoni:

2000-05-03

Karatteristiċi tal-prodott

                                SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF VETERINARY MEDICINAL PRODUCT
Amoxycare, 250mg, hard capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each capsule contains:
Active Ingredient
mg per capsule
Amoxicillin
250
(as Amoxicillin trihydrate)
Capsule Body:
Erythrosin (E127)
0.0011
Quinoline yellow (E104)
0.00329
Titanium dioxide (E171)
0.48311
Capsule Cap:
Erythrosin (E127)
0.549
Ferric Oxide Red (E172)
0.244
Titanium dioxide (E171)
1.1952
Ink:
Black Iron Oxide (E172)
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Capsule, hard.
Red and white coloured hard gelatine capsule with the logo, AMOX 250,
printed in black ink.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product is indicated in the treatment and control of diseases
caused by or
associated with bacterial pathogens sensitive to Amoxycillin. These
include
the following groups of pathogens.
_Pasturella spp._
_Staphylococci _(penicillin sensitive strains)
_Streptococci_
When susceptible organisms are present treatment may be effective in
the
following indications:
localised infections
alimentary tract infections
respiratory infections
urogenital tract infections
secondary bacterial infections
general infections
4.3
CONTRAINDICATIONS
Not to be administered to animals known to be sensitive to beta-lactam
antibiotics.
Do not treat dogs less than 10kg bodyweight.
Not to be administered to small herbivores.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
As with all penicillins, the product may cause hypersensitivity
(allergy)
following ingestion. It should not be used when the dog is known to be
allergic to penicillins.
As with all other penicillins, bacterial resistance to amoxycillin may
occur.
Thus antibiotic sensitivity testing should be considered if a clinical
condition
fails to respond to treatment within 5 days.
In common with many antibiotics, administration of amoxycillin may
disturb
the gut flora.
4.5
SPECIAL PRECAUTIONS FOR USE
(I)
PRECAUTIONS FOR USE IN ANIMAL
                                
                                Aqra d-dokument sħiħ
                                
                            

Fittex twissijiet relatati ma 'dan il-prodott